Alemtuzumab (Campath(Registered Trademark)) to Treat T-Large Granular Lymphocyte Leukemia

This study is currently recruiting participants.

Study NCT00345345 Information provided by National Institutes of Health Clinical Center (CC)

First Received: June 27, 2006 Last Updated: December 23, 2011 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is currently recruiting participants.
Estimated Study Completion Date:	June 2014
Estimated Primary Completion Date:	June 2014 (Final data collection date for primary outcome measure)